Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
boston blog main
boston top stories
9
×
boulder/denver blog main
boulder/denver top stories
detroit blog main
detroit top stories
gilead sciences
9
×
indiana blog main
indiana top stories
life sciences
national
national blog main
national top stories
new york blog main
new york top stories
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
san francisco blog main
san francisco top stories
seattle blog main
seattle top stories
9
×
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
alzheimer's disease
biotech
deals
gene therapy
startups
cancer immunotherapy
europe blog main
europe top stories
fda
merck
nonalcoholic steatohepatitis
novartis
pfizer
What
bio
roundup
9
×
drug
cancer
new
pfizer’s
acquisitions
amid
biggest
biogen
biogen’s
bombast
caught
ceo
coronavirus
crispr
debate
develop
discussion
efforts
isn’t
meso’s
miss
nash
news
pandemic
pharma
presidential
promise
response
tuesday’s
vaccine
viewers
week
abbvie’s
activity
aducanumab
ahead
albert
alzheimer’s
Language
unset
unknown
Current search:
roundup
×
" gilead sciences "
×
" seattle top stories "
×
" boston top stories "
×
@xconomy.com
3 years ago
Bio Roundup: MESO’s Miss, Pfizer’s Cancer Bet, Vaccine Promise & More
@xconomy.com
3 years ago
Bio Roundup: MESO’s Miss, Pfizer’s Cancer Bet, Vaccine Promise & More
@xconomy.com
3 years ago
Bio Roundup: SeaGen Scores, Dyne’s Debut, Microbiome Moves & More
@xconomy.com
3 years ago
Bio Roundup: Pharma M&A, AbbVie’s Cancer Bet, Biofourmis Bucks & More
@xconomy.com
4 years ago
Bio Roundup: Fast FDA Approvals, Biogen Delays, ORIC’s IPO & More
@xconomy.com
4 years ago
Bio Roundup: Pfizer’s Future, CRISPR in Patients, Drug Imports & More
@xconomy.com
5 years ago
Bio Roundup: Biogen’s Strategy, Drug Price Convo, NASH News & More
@xconomy.com
5 years ago
Bio Roundup: Amyloid Angst, NASH News, Brammer Bagged & More
@xconomy.com
5 years ago
Bio Roundup: New CRISPR Feud, A NY Splash, Pharma vs. Congress & More